Get Live Data

If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. HYVE.L Share Price
  4. HYVE.L Share Regulatory News
  5. Director Declaration

Pin to quick picksHYVE.L Regulatory News (HYVE)

HYVE.L Information
  • There is currently no data for HYVE

Director Declaration

22 Jan 2016 09:28

RNS Number : 7174M
ITE Group PLC
22 January 2016
 

 

22 January 2016

ITE Group Plc (the 'Company')

 

CHANGE IN DIRECTOR'S PARTICULARS

 

Pursuant to Listing Rule 9.6.14, the Company reports that Sharon Baylay (Non-Executive Director) has been appointed to the Board of Market Tech Holdings Limited as a Non-Executive Director with effect from 1 February 2016.

 

Anneka Milham

Company Secretary - ITE Group Plc

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNSEMSUEFMSEEF
456789101112
Date   Source Headline
21st Mar 202311:02 amRNSForm 8.3 - Hyve Group Plc
21st Mar 202310:25 amRNSForm 8.3 - Hyve Group plc
21st Mar 202310:11 amRNSForm 8.5 (EPT/RI) - Hyve Group PLC
21st Mar 20239:49 amRNSForm 8.5 (EPT/RI)
20th Mar 20232:05 pmRNSForm 8.5 (EPT/RI) - Amendment
20th Mar 20231:32 pmRNSForm 8.3 - Hyve Group plc
20th Mar 202312:00 pmRNSForm 8.3 - Hyve Group plc Amendment
20th Mar 202310:51 amRNSForm 8.3 - Hyve Group plc
20th Mar 202310:31 amRNSForm 8.3 - Hyve Group Plc
20th Mar 20239:32 amRNSForm 8.3 - Hyve Group Plc
20th Mar 20238:09 amRNSForm 8.5 (EPT/RI)
20th Mar 20237:00 amRNSStandard form for notification of major holdings
17th Mar 20233:58 pmRNSStandard form for notification of major holdings
17th Mar 20233:00 pmBUSForm 8.3 - HYVE LN
17th Mar 20231:50 pmRNSForm 8.3 - Hyve Group PLC
17th Mar 202312:18 pmRNSForm 8.3 - Hyve Group plc
17th Mar 202312:14 pmRNSForm 8.3 - Hyve Group plc
17th Mar 202311:57 amRNSForm 8.3 - Hyve Group Plc
17th Mar 202311:47 amRNSForm 8.5 (EPT/RI) - Amendment
17th Mar 202311:41 amRNSForm 8.5 (EPT/RI)
17th Mar 202310:22 amRNSForm 8.3 - Hyve Group Plc
17th Mar 202310:20 amRNSForm 8.3 - Hyve Group Plc
17th Mar 202310:08 amRNSForm 8.3 - Hyve Group plc
17th Mar 202310:03 amRNSAmended - Form 8.5 (EPT/RI) - Hyve Group PLC
17th Mar 20239:59 amRNSStandard form for notification of major holdings
16th Mar 20235:47 pmRNSStandard form for notification of major holdings
16th Mar 20235:13 pmRNSStandard form for notification of major holdings
16th Mar 20233:22 pmRNSForm 8.3 - Hyve Group Plc
16th Mar 20233:10 pmRNSStandard form for notification of major holdings
16th Mar 20233:00 pmBUSForm 8.3 - HYVE LN
16th Mar 20232:10 pmRNSForm 8.3 - Hyve Group plc
16th Mar 20232:10 pmRNSForm 8.3 - Hyve Group plc
16th Mar 202312:03 pmRNSForm 8.3 - Hyve Group Plc
16th Mar 202311:51 amRNSForm 8.3 - HYVE GROUP PLC
16th Mar 202311:35 amRNSForm 8.3 - Hyve Group Plc
16th Mar 202311:32 amRNSForm 8.5 (EPT/RI)
16th Mar 202310:01 amGNWForm 8.3 - Hyve Group Plc
16th Mar 20239:51 amRNSForm 8.5 (EPT/RI) - Hyve Group PLC
15th Mar 20233:32 pmRNSForm 8.3 - Hyve Group plc
15th Mar 20231:51 pmRNSForm 8.3 - HYVE GROUP PLC
15th Mar 202311:20 amRNSForm 8.5 (EPT/RI)
15th Mar 202310:48 amGNWForm 8.3 - Hyve Group Plc
15th Mar 20239:40 amRNSForm 8.3 - Hyve Group Plc
15th Mar 20239:38 amRNSForm 8.3 - Hyve Group plc
15th Mar 20237:00 amRNSOffer for Hyve Group plc
14th Mar 20233:20 pmRNSForm 8.3 - Hyve Group plc
14th Mar 20231:28 pmRNSForm 8.3 - Hyve Group plc
14th Mar 202311:50 amRNSForm 8.5 (EPT/RI)
14th Mar 202311:09 amGNWForm 8.3 - Hyve Group Plc
14th Mar 202310:26 amRNSForm 8.3 - Hyve Group plc
456789101112

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
PFD
Premier Foods
LSE
-0.97%
EDL
EDL.L
LSE
0.00%
LOK
Lok N Store
LSE
0.00%
STAN
Standard Chartered
LSE
1.53%
HFEL
Hend.far East
LSE
1.95%
Trending
OMI
Orosur Mining
LSE
1.41%
IMM
Immupharma
LSE
4.35%
RKH
Rockhopper
LSE
1.36%
HEMO
Hemogenyx Pharmaceuticals
LSE
2.67%
AVCT
Avacta Group
LSE
0.69%